Document is current

Any future updates will be listed below

Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy

Crossref DOI link: https://doi.org/10.1186/s13104-015-1518-9

Published Online: 2015-10-17

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark